Acelyrin, Inc. Profile Avatar - Palmy Investing

Acelyrin, Inc.

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to…

Biotechnology
US, Agoura Hills [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Acelyrin, Inc. has no acquisition track records yet.

M&A Deals · History

Acelyrin, Inc. has no acquisition track records yet.

End of SLRN's Analysis
CIK: 1962918 CUSIP: 00445A100 ISIN: US00445A1007 LEI: - UEI: -
Secondary Listings
SLRN has no secondary listings inside our databases.